Holen Sie sich die Stockscreener-App
15.84
1.86%
-0.30
Handel nachbörslich:
15.55
-0.29
-1.83%
Schlusskurs vom Vortag:
$16.14
Offen:
$16.29
24-Stunden-Volumen:
32,302
Relative Volume:
1.13
Marktkapitalisierung:
$103.21M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-61.23M
KGV:
-9.7178
EPS:
-1.63
Netto-Cashflow:
$22.49M
1W Leistung:
-3.47%
1M Leistung:
-13.16%
6M Leistung:
+9.02%
1J Leistung:
+83.33%
1-Tages-Spanne:
$15.55
$16.44
1-Wochen-Bereich:
$15.55
$17.48
52-Wochen-Spanne:
$7.692
$19.93
Assembly Biosciences Inc Stock (ASMB) Company Profile
Firmenname
Assembly Biosciences Inc
Sektor
Branche
Telefon
(833) 409-4583
Adresse
TWO TOWER PLACE, SOUTH SAN FRANCISCO
Vergleichen Sie ASMB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| ASMB | 15.84 | 103.21M | 0 | -61.23M | 22.49M | -1.63 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Assembly Biosciences Inc Stock (ASMB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-09-13 | Eingeleitet | H.C. Wainwright | Neutral |
| 2021-09-02 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-03-23 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-11-06 | Herabstufung | Jefferies | Buy → Hold |
| 2020-10-19 | Eingeleitet | Truist | Buy |
| 2019-10-16 | Eingeleitet | Mizuho | Buy |
| 2018-11-19 | Eingeleitet | Leerink Partners | Outperform |
| 2018-10-08 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2018-08-08 | Eingeleitet | Robert W. Baird | Outperform |
| 2018-04-13 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2018-01-05 | Eingeleitet | B. Riley FBR, Inc. | Neutral |
| 2017-11-08 | Eingeleitet | Jefferies | Buy |
| 2017-05-30 | Eingeleitet | Chardan Capital Markets | Buy |
Alle ansehen
Assembly Biosciences Inc Aktie (ASMB) Neueste Nachrichten
(ASMB) Pivots Trading Plans and Risk Controls - Stock Traders Daily
ARMISTICE CAPITAL, LLC Adjusts Stake in Assembly Biosciences Inc - GuruFocus.com
What is HC Wainwright's Forecast for ASMB FY2024 Earnings? - MarketBeat
Assembly Biosciences, Inc. (NASDAQ:ASMB) Short Interest Down 51.2% in October - MarketBeat
Analysts Just Slashed Their Assembly Biosciences, Inc. (NASDAQ:ASMB) EPS Numbers - Simply Wall St
Bearish: Analysts Just Cut Their Assembly Biosciences, Inc. (NASDAQ:ASMB) Revenue and EPS estimates - Yahoo Finance
Analyzing Taysha Gene Therapies (NASDAQ:TSHA) & Gilead Sciences (NASDAQ:GILD) - Defense World
Assembly Biosciences: Q3 Earnings Snapshot - CTPost
Assembly Biosciences initiates at-the-market equity program - Investing.com India
Assembly Biosciences Inc (ASMB) Reports Q3 2024 Revenue of $6.8M, GAAP EPS Loss of $1.51, Misses Estimates - GuruFocus.com
Assembly Biosciences Reports Third Quarter 2024 Financial Results and Recent Updates - The Manila Times
Marquis Who's Who Honors Jonathan Colon, PhD, for Expertise in Biotechnology - 24-7 Press Release
Assembly Biosciences (NASDAQ:ASMB) Stock Crosses Above 200-Day Moving AverageShould You Sell? - MarketBeat
When (ASMB) Moves Investors should Listen - Stock Traders Daily
Baker Lab’s AI-Driven Antibody Cage Technology Unlocked as Archon Biosciences - Genetic Engineering & Biotechnology News
Short Interest in Assembly Biosciences, Inc. (NASDAQ:ASMB) Declines By 7.9% - MarketBeat
Assembly Biosciences (NASDAQ:ASMB) Share Price Crosses Above 200 Day Moving AverageHere's Why - MarketBeat
(ASMB) Investment Analysis and Advice - Stock Traders Daily
Microbiome Manufacturing Market Poised for Robust Growth at 15.4% CAGR by 2031 - WhaTech
Assembly Biosciences (NASDAQ:ASMB) Shares Pass Above 200-Day Moving AverageTime to Sell? - MarketBeat
Assembly Biosciences, Inc. (NASDAQ:ASMB) Short Interest Update - MarketBeat
Assembly Biosciences, Inc.'s (NASDAQ:ASMB) market cap surged US$16m last week, individual investors who have a lot riding on the company were rewarded - Simply Wall St
Assembly Biosciences sees major stock purchase by investor Alexander Schornstein By Investing.com - Investing.com Canada
Alexander Schornstein Purchases 10,000 Shares of Assembly Biosciences, Inc. (NASDAQ:ASMB) Stock - MarketBeat
Assembly Biosciences (NASDAQ:ASMB) Share Price Crosses Above 200-Day Moving AverageTime to Sell? - MarketBeat
Assembly Biosciences CEO sells shares worth $2,917 to cover taxes By Investing.com - Investing.com South Africa
Assembly Biosciences CEO sells shares worth $2,917 to cover taxes - Investing.com India
How To Trade (ASMB) - Stock Traders Daily
Assembly Biosciences executive sells shares worth $2,325 By Investing.com - Investing.com South Africa
Assembly Biosciences executive sells shares worth $2,325 - Investing.com India
Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year? - Yahoo Finance
Assembly Biosciences, Inc. (NASDAQ:ASMB) Sees Significant Growth in Short Interest - MarketBeat
Armistice Capital LLC Makes New Investment in Assembly Biosciences, Inc. (NASDAQ:ASMB) - MarketBeat
Investment Analysts’ Updated EPS Estimates for September 24th (AB, AG, AIOT, AIR, AMWL, ASMB, BAG, BDTX, BHVN, BIIB) - Defense World
Assembly Biosciences (NASDAQ:ASMB) Rating Reiterated by HC Wainwright - MarketBeat
(ASMB) Trading Signals - Stock Traders Daily
Assembly Biosciences advances genital herpes treatment study - Investing.com
Assembly Biosciences' Investigational Herpes Treatment Shows Antiviral Efficacy, Safety In Healthy Participants - AOL
Tonight | The Assembly on ABC and ABC iview S1E6 - TV Central
Assembly Biosciences Reports Positive Interim Phase 1a Results from Clinical Trial Evaluating Long-Acting - EIN News
Assembly Biosciences Reports Positive Interim Phase 1a Results from Clinical Trial Evaluating Long-Acting Helicase-Primase Inhibitor Candidate ABI-5366 - StockTitan
The Assembly: Sept 24 - TV Tonight
Jefferies sees upside in Assembly Biosciences stock ahead of key Phase IA data - Investing.com
Schlumberger Limited (NYSE:SLB) Holdings Lifted by Richardson Financial Services Inc. - Defense World
Assembly Biosciences (NASDAQ:ASMB) Upgraded to Buy by Jefferies Financial Group - MarketBeat
Assembly Coffee closing after two years in Ballard - My Ballard
Finanzdaten der Assembly Biosciences Inc-Aktie (ASMB)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):